Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
J Am Soc Nephrol ; 32(8): 1961-1973, 2021 08.
Article in English | MEDLINE | ID: mdl-34045313

ABSTRACT

BACKGROUND: Mutations in COL4A5 are responsible for 80% of cases of X-linked Alport Syndrome (XLAS). Although genes that cause AS are well characterized, people with AS who have similar genetic mutations present with a wide variation in the extent of kidney impairment and age of onset, suggesting the activities of modifier genes. METHODS: We created a cohort of genetically diverse XLAS male and female mice using the Diversity Outbred mouse resource and measured albuminuria, GFR, and gene expression. Using a quantitative trait locus approach, we mapped modifier genes that can best explain the underlying phenotypic variation measured in our diverse population. RESULTS: Genetic analysis identified several loci associated with the variation in albuminuria and GFR, including a locus on the X chromosome associated with X inactivation and a locus on chromosome 2 containing Fmn1. Subsequent analysis of genetically reduced Fmn1 expression in Col4a5 knockout mice showed a decrease in albuminuria, podocyte effacement, and podocyte protrusions in the glomerular basement membrane, which support the candidacy of Fmn1 as a modifier gene for AS. CONCLUSION: With this novel approach, we emulated the variability in the severity of kidney phenotypes found in human patients with Alport Syndrome through albuminuria and GFR measurements. This approach can identify modifier genes in kidney disease that can be used as novel therapeutic targets.


Subject(s)
Albuminuria/urine , Collagen Type IV/genetics , Creatinine/urine , Formins/genetics , Nephritis, Hereditary/genetics , Albuminuria/etiology , Animals , Chromosome Mapping , Disease Models, Animal , Female , Formins/ultrastructure , Gene Expression , Glomerular Filtration Rate , Male , Mice , Mice, Knockout , Microscopy, Electron, Transmission , Mutation , Nephritis, Hereditary/complications , Nephritis, Hereditary/physiopathology , Phenotype , Podocytes/pathology , Proof of Concept Study , Quantitative Trait Loci , RNA-Seq , Sex Factors , Whole Genome Sequencing
2.
Physiol Genomics ; 50(8): 543-552, 2018 08 01.
Article in English | MEDLINE | ID: mdl-29652635

ABSTRACT

Mesangial matrix expansion is an important process in the initiation of chronic kidney disease, yet the genetic factors driving its development are unknown. Our previous studies have implicated Far2 as a candidate gene associated with differences in mesangial matrix expansion between mouse inbred strains. Consistent with the hypothesis that increased expression of Far2 leads to mesangial matrix expansion through increased production of platelet-activating factor precursors, we show that FAR2 is capable of mediating de novo platelet-activating factor synthesis in vitro and driven by the transcription factor NKX3.2. We demonstrate that knockdown of Far2 in mice delays the progression of mesangial matrix expansion with at least six months (equivalent to ~15 yr in human). Furthermore, we show that increased FAR2 expression in human patients is associated with diabetic nephropathy, lupus nephritis, and IgA nephropathy. Taken together, these results highlight FAR2's role in the development of mesangial matrix expansion and chronic kidney disease.


Subject(s)
Aldehyde Oxidoreductases/genetics , Diabetic Nephropathies/genetics , Glomerular Mesangium/metabolism , Adult , Aged , Aldehyde Oxidoreductases/metabolism , Animals , Diabetic Nephropathies/metabolism , Female , Glomerular Mesangium/pathology , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Humans , Male , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Knockout , Middle Aged , Transcription Factors/genetics , Transcription Factors/metabolism , Young Adult
3.
Endocrinology ; 158(9): 2707-2712, 2017 09 01.
Article in English | MEDLINE | ID: mdl-28633442

ABSTRACT

Previous studies with continuous glucose monitoring in mice have been limited to several days or weeks, with the mouse's physical attachment to the equipment affecting behavior and measurements. In the current study, we measured blood glucose and body temperature at 10-second intervals for 12 weeks in a cohort of NOD/ShiLtJ female mice using wireless telemetry. This allowed us to obtain a high-resolution profile of the circadian rhythm of these two parameters and the onset of hyperglycemic development in real time. The most striking observations were the elevated nocturnal concentrations of glucose into the diabetic range days before elevations in diurnal glucose (when glucose concentrations are historically measured) and the strong, negative correlation between elevated blood glucose concentrations and body temperature with a steady decline of the body temperature with diabetes development. Taken together, this technological advancement provides improved resolution in the study of the disease trajectory of diabetes in mouse models, including relevant translatability to the current technologies of continuous glucose monitoring now regularly used in patients.


Subject(s)
Blood Glucose/analysis , Body Temperature/physiology , Circadian Rhythm/physiology , Telemetry/methods , Wireless Technology , Animals , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Disease Progression , Female , Glucose Tolerance Test , Hyperglycemia/metabolism , Hyperglycemia/pathology , Mice , Mice, Inbred NOD
4.
J Am Soc Nephrol ; 27(11): 3271-3277, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27020856

ABSTRACT

Changes in metabolite levels of the kynurenine pathway have been observed in patients with CKD, suggesting involvement of this pathway in disease pathogenesis. Our recent genetic analysis in the mouse identified the kynurenine 3-mono-oxygenase (KMO) gene (Kmo) as a candidate gene associated with albuminuria. This study investigated this association in more detail. We compared KMO abundance in the glomeruli of mice and humans under normal and diabetic conditions, observing a decrease in glomerular KMO expression with diabetes. Knockdown of kmo expression in zebrafish and genetic deletion of Kmo in mice each led to a proteinuria phenotype. We observed pronounced podocyte foot process effacement on long stretches of the filtration barrier in the zebrafish knockdown model and mild podocyte foot process effacement in the mouse model, whereas all other structures within the kidney remained unremarkable. These data establish the candidacy of KMO as a causal factor for changes in the kidney leading to proteinuria and indicate a functional role for KMO and metabolites of the tryptophan pathway in podocytes.


Subject(s)
Gene Deletion , Kynurenine 3-Monooxygenase/genetics , Proteinuria/enzymology , Proteinuria/genetics , Animals , Female , Humans , Kynurenine 3-Monooxygenase/physiology , Male , Mice , Mice, Inbred C57BL , Zebrafish
5.
PLoS One ; 9(10): e111308, 2014.
Article in English | MEDLINE | ID: mdl-25353171

ABSTRACT

BACKGROUND: Renal aging is characterized by functional and structural changes like decreased glomerular filtration rate, and glomerular, tubular and interstitial damage. To gain insight in pathways involved in renal aging, we studied aged mouse strains and used genetic analysis to identify genes associated with aging phenotypes. METHODS: Upon morphological screening in kidneys from 20-month-old mice from 26 inbred strains we noted intracapillary PAS-positive deposits. The severity of these deposits was quantified by scoring of a total of 50 glomeruli per section (grade 0-4). Electron microscopy and immunohistochemical staining for apoE, apoB, apoA-IV and perilipin-2 was performed to further characterize the lesions. To identify loci associated with these PAS-positive intracapillary glomerular deposits, we performed haplotype association mapping. RESULTS: Six out of 26 mouse strains showed glomerular PAS-positive deposits. The severity of these deposits varied: NOD(0.97), NZW(0.41), NON(0.30), B10(0.21), C3 H(0.9) and C57BR(0.7). The intracapillary deposits were strongly positive for apoE and weakly positive for apoB and apoA-IV. Haplotype association mapping showed a strong association with a 30-Kb haplotype block on Chr 1 within the Esrrg gene. We investigated 1 Mb on each site of this region, which includes the genes Spata17, Gpatch2, Esrrg, Ush2a and Kctd3. CONCLUSIONS: By analyzing 26 aged mouse strains we found that some strains developed an intracapillary PAS and apoE-positive lesion and identified a small haplotype block on Chr 1 within the Esrrg gene to be associated with these lipoprotein deposits. The region spanning this haplotype block contains the genes Spata17, Gpatch2, Esrrg, Ush2a and Kctd3, which are all highly expressed in the kidney. Esrrg might be involved in the evolvement of these glomerular deposits by influencing lipid metabolism and possibly immune reponses.


Subject(s)
Aging/metabolism , Apolipoproteins/metabolism , Carrier Proteins/metabolism , Genetic Linkage , Genetic Loci , Kidney Glomerulus/metabolism , Phosphoproteins/metabolism , Aging/genetics , Animals , Apolipoproteins/genetics , Carrier Proteins/genetics , Haplotypes , Kidney Glomerulus/growth & development , Kidney Glomerulus/ultrastructure , Male , Mice , Mice, Inbred Strains , Perilipin-1 , Phosphoproteins/genetics
6.
Exp Mol Pathol ; 93(3): 455-61, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23026400

ABSTRACT

Lung cancer is the most common cause of cancer-related deaths in both men and women, and effective preventatives are rare due to the difficulty of early detection. Specific gene expression signatures have been identified in individuals that already developed lung cancer. To identify if gene expression differences could be detected in individuals before the onset of the disease, we obtained lung tissues for microarray analysis from young, healthy mice of 9 inbred strains with known differences in their susceptibility to spontaneous pulmonary adenomas when aged. We found that the most common differentially expressed genes among all possible 36 strain comparisons showed significant associations with cancer- and inflammation-related processes. Significant expression differences between susceptible and resistant strains were detected for Aldh3a1, Cxcr1 and 7, Dpt, and Nptx1-genes with known cancer-related functions, and Cd209, Cxcr1 and 7, and Plag2g1b-genes with known inflammatory-related functions. Whereas Aldh3a1, Cd209, Dpt, and Pla2g1b had increased expression, Cxcr1 and 7, and Nptx1 had decreased expression in strains susceptible to pulmonary adenomas. Thus, our study shows that expression differences between susceptible and resistant strains can be detected in young and healthy mice without manifestation of pulmonary adenomas and, thus, may provide an opportunity of early detection. Finally, the identified genes have previously been reported for human non-small cell lung cancer suggesting that molecular pathways may be shared between these two cancer types.


Subject(s)
Adenoma/genetics , Gene Expression Regulation, Neoplastic , Genetic Predisposition to Disease , Lung Neoplasms/genetics , Mice, Inbred Strains/genetics , Animals , Mice , Species Specificity
7.
Mol Genet Genomics ; 287(11-12): 845-54, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23011808

ABSTRACT

Chronic kidney disease is a common disease with increasing prevalence in the western population. One common reason for chronic kidney failure is diabetic nephropathy. Diabetic nephropathy and hyperglycemia are characteristics of the mouse inbred strain KK/HlJ, which is predominantly used as a model for metabolic syndrome due to its inherited glucose intolerance and insulin resistance. We used KK/HlJ, an albuminuria-sensitive strain, and C57BL/6J, an albuminuria-resistant strain, to perform a quantitative trait locus (QTL) cross to identify the genetic basis for chronic kidney failure. Albumin-creatinine ratio (ACR) was measured in 130 F2 male offspring. One significant QTL was identified on chromosome (Chr) X and four suggestive QTL were found on Chrs 6, 7, 12, and 13. Narrowing of the QTL region was focused on the X-linked QTL and performed by incorporating genotype and expression analyses for genes located in the region. From the 485 genes identified in the X-linked QTL region, a few candidate genes were identified using a combination of bioinformatic evidence based on genomic comparison of the parental strains and known function in urine homeostasis. Finally, this study demonstrates the significance of the X chromosome in the genetic determination of albuminuria.


Subject(s)
Albuminuria/genetics , Gene Expression Regulation , Genes, X-Linked , Kidney/physiology , Quantitative Trait Loci , Albumins/analysis , Albuminuria/metabolism , Animals , Creatinine/analysis , Female , Kidney Failure, Chronic/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Polymorphism, Single Nucleotide , X Chromosome
8.
PLoS One ; 7(8): e43139, 2012.
Article in English | MEDLINE | ID: mdl-22912808

ABSTRACT

Despite considerable progress understanding genes that affect the HDL particle, its function, and cholesterol content, genes identified to date explain only a small percentage of the genetic variation. We used N-ethyl-N-nitrosourea mutagenesis in mice to discover novel genes that affect HDL cholesterol levels. Two mutant lines (Hlb218 and Hlb320) with low HDL cholesterol levels were established. Causal mutations in these lines were mapped using linkage analysis: for line Hlb218 within a 12 Mbp region on Chr 10; and for line Hlb320 within a 21 Mbp region on Chr 7. High-throughput sequencing of Hlb218 liver RNA identified a mutation in Pla2g12b. The transition of G to A leads to a cysteine to tyrosine change and most likely causes a loss of a disulfide bridge. Microarray analysis of Hlb320 liver RNA showed a 7-fold downregulation of Hpn; sequencing identified a mutation in the 3' splice site of exon 8. Northern blot confirmed lower mRNA expression level in Hlb320 and did not show a difference in splicing, suggesting that the mutation only affects the splicing rate. In addition to affecting HDL cholesterol, the mutated genes also lead to reduction in serum non-HDL cholesterol and triglyceride levels. Despite low HDL cholesterol levels, the mice from both mutant lines show similar atherosclerotic lesion sizes compared to control mice. These new mutant mouse models are valuable tools to further study the role of these genes, their affect on HDL cholesterol levels, and metabolism.


Subject(s)
Cholesterol, HDL/metabolism , Ethylnitrosourea , Genetic Variation , Models, Animal , Phospholipases A2/genetics , Serine Endopeptidases/genetics , Alkaline Phosphatase/blood , Analysis of Variance , Animals , Antisense Elements (Genetics)/genetics , Blotting, Northern , Blotting, Western , Chromosome Mapping , Crosses, Genetic , Evoked Potentials, Auditory, Brain Stem , High-Throughput Nucleotide Sequencing , Lipids/blood , Lod Score , Mice , Mice, Inbred C57BL , Microarray Analysis , Mutagenesis/genetics , Species Specificity , Thyroxine/blood
9.
Physiol Genomics ; 43(1): 1-11, 2011 Jan 07.
Article in English | MEDLINE | ID: mdl-20823217

ABSTRACT

Lung function detection in mice is currently most accurately measured by invasive techniques, which are costly, labor intensive, and terminal. This limits their use for large-scale or longitudinal studies. Noninvasive assays are often used instead, but their accuracy for measuring lung function parameters such as resistance and elastance has been questioned in studies involving small numbers of mouse strains. Here we compared parameters detected by two different methods using 29 inbred mouse strains: enhanced pause (Penh), detected by unrestrained plethysmography, and central airway resistance and lung elastance, detected by a forced oscillation technique. We further tested whether the phenotypic variations were determined by the same genomic location in genome-wide association studies using a linear mixed model algorithm. Penh, resistance, and elastance were measured in nonexposed mice or mice exposed to saline and increasing doses of aerosolized methacholine. Because Penh differed from airway resistance in several strains and because the peak genetic associations found for Penh, resistance, or elastance were located at different genomic regions, we conclude that using Penh as an indicator for lung function changes in high-throughput genetic studies (i.e., genome-wide association studies or quantitative trait locus studies) measures something fundamentally different than airway resistance and lung elastance.


Subject(s)
Airway Resistance/physiology , Plethysmography/methods , Airway Resistance/drug effects , Algorithms , Animals , Female , Genome-Wide Association Study , Male , Methacholine Chloride/pharmacology , Mice , Quantitative Trait Loci
10.
J Lipid Res ; 49(11): 2452-62, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18632552

ABSTRACT

In an effort to discover new mouse models of cardiovascular disease using N-ethyl-N-nitrosourea (ENU) mutagenesis followed by high-throughput phenotyping, we have identified a new mouse mutation, C699Y, in the LDL receptor (Ldlr), named wicked high cholesterol (WHC). When WHC was compared with the widely used Ldlr knockout (KO) mouse, notable phenotypic differences between strains were observed, such as accelerated atherosclerotic lesion formation and reduced hepatosteatosis in the ENU mutant after a short exposure to an atherogenic diet. This loss-of-function mouse model carries a single base mutation in the Ldlr gene on an otherwise pure C57BL/6J (B6) genetic background, making it a useful new tool for understanding the pathophysiology of atherosclerosis and for evaluating additional genetic modifiers regulating hyperlipidemia and atherogenesis. Further investigation of genomic differences between the ENU mutant and KO strains may reveal previously unappreciated sequence functionality.


Subject(s)
Ethylnitrosourea/administration & dosage , Mutagenesis/drug effects , Mutagenesis/genetics , Mutagens/administration & dosage , Mutation, Missense/genetics , Receptors, LDL/genetics , Amino Acid Sequence , Animals , Base Sequence , Disease Models, Animal , Female , Hyperlipoproteinemia Type II/chemically induced , Hyperlipoproteinemia Type II/genetics , Hyperlipoproteinemia Type II/pathology , Male , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Knockout , Molecular Sequence Data , Receptors, LDL/deficiency
11.
J Immunol ; 170(5): 2742-9, 2003 Mar 01.
Article in English | MEDLINE | ID: mdl-12594305

ABSTRACT

Nonobese diabetic (NOD) mice and some human type 1 diabetes (T1D) patients manifest low to high levels of other autoimmune pathologies. Skewing their cytokine production from a Th1 (primarily IFN-gamma) to a Th2 (primarily IL-4 and IL-10) pattern is a widely proposed approach to dampen the pathogenicity of autoreactive diabetogenic T cells. However, it is important that altered cytokine balances not enhance any other autoimmune proclivities to dangerous levels. Murine CD4 T cells are characterized by a reciprocal relationship between the production of IFN-gamma and expression of the beta-chain component of its receptor (IFN-gamma RB). Thus, NOD mice constitutively expressing a CD2 promoter-driven IFN-gamma RB transgene in all T cells are Th1-deficient. Unexpectedly, NOD.IFN-gamma RB Tg mice were found to develop a lethal early paralytic syndrome induced by a CD8 T cell-dependent autoimmune-mediated myositis. Furthermore, pancreatic insulitis levels were not diminished in 9-wk-old NOD.IFN-gamma RB Tg females, and overt T1D developed in the few that survived to an older age. Autoimmune-mediated myositis is only occasionally detected in standard NOD mice. Hence, some manipulations diminishing Th1 responses can bring to the forefront what are normally secondary autoimmune pathologies in NOD mice, while also failing to dependably abrogate pancreatic beta cell destruction. This should raise a cautionary note when considering the use of protocols that induce alterations in cytokine balances as a means of blocking progression to overt T1D in at-risk humans.


Subject(s)
Cytokines/deficiency , Diabetes Mellitus, Type 1/immunology , Interferon-gamma/metabolism , Nervous System Autoimmune Disease, Experimental/immunology , Paralysis/immunology , Receptors, Interferon/genetics , Th1 Cells/immunology , Transgenes/immunology , Adoptive Transfer , Animals , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/pathology , Cell Movement/genetics , Cell Movement/immunology , Cytokines/genetics , Diabetes Mellitus, Type 1/genetics , Diabetes Mellitus, Type 1/pathology , Female , Gene Expression Regulation/immunology , Interferon-gamma/antagonists & inhibitors , Kinetics , Macrophages/pathology , Mice , Mice, Inbred C57BL , Mice, Inbred NOD , Mice, SCID , Mice, Transgenic , Nervous System Autoimmune Disease, Experimental/genetics , Nervous System Autoimmune Disease, Experimental/mortality , Nervous System Autoimmune Disease, Experimental/pathology , Paralysis/genetics , Paralysis/mortality , Paralysis/pathology , Receptors, Interferon/biosynthesis , Sex Characteristics , Spleen/immunology , Spleen/pathology , Spleen/transplantation , Th1 Cells/metabolism , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/metabolism , Interferon gamma Receptor
SELECTION OF CITATIONS
SEARCH DETAIL
...